3% boost for NIH passed in Senate

US Senators last night (March 10) passed the long-delayed $410 billion omnibus spending bill that includes $30.3 billion for the National Institutes of Health in FY09. President Barack Obama is expected to sign the legislation today. The NIH allotment would be a $938 million boost over the agency's FY08 budget - a 3% increase, which roughly tracks inflation. The National Science Foundation is set to get nearly $6.5 billion in FY09, a 5.9% increase over its FY08 budget. In addition, the Departm

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
US Senators last night (March 10) passed the long-delayed $410 billion omnibus spending bill that includes $30.3 billion for the National Institutes of Health in FY09. President Barack Obama is expected to sign the legislation today. The NIH allotment would be a $938 million boost over the agency's FY08 budget - a 3% increase, which roughly tracks inflation. The National Science Foundation is set to get nearly $6.5 billion in FY09, a 5.9% increase over its FY08 budget. In addition, the Department of Energy's Office of Science would be working with a $4.77 billion FY09 budget, a whopping 18.8% increase over FY08. Republican and Democratic legislators linkurl:wrangled;http://www.the-scientist.com/community/posts/list/411.page with the bill's multitude of earmarks for months before agreeing to pass the measure by a 62-35 vote in the Senate.
**__Related stories:__***linkurl:Life science scores in 2010 budget;http://www.the-scientist.com/blog/display/55483/
[26th February 2009]*linkurl:NIH: stimulated but flat;http://www.the-scientist.com/blog/display/55453/
[24th February 2009]*linkurl:Flat funding for NIH in 2009;http://www.the-scientist.com/blog/display/55450/
[23rd February 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies